A real-world, retrospective study to assess the effectiveness and safety of siponimod in Chinese patients with relapsing forms of multiple sclerosis

被引:0
作者
Zhang, Yao [1 ]
Liu, Hongbo [2 ]
Zhou, Ming [3 ]
Li, Zheng [3 ]
Li, Bingbing [4 ]
Cai, Min [3 ]
Shi, Xiaofang [3 ]
Liu, Lyra [3 ]
Lin, Anne [5 ]
Xu, Yan [1 ]
机构
[1] Peking Union Med Coll Hosp, Beijing, Peoples R China
[2] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China
[3] China Novartis Inst Biomed Res, Shanghai, Peoples R China
[4] Novartis Pharmaceut, E Hanover, NJ USA
[5] IQVIA Quintiles IMS, Taipei, Taiwan
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P1741/928
引用
收藏
页码:1100 / 1100
页数:1
相关论文
共 50 条
[21]   Effectiveness and safety of finerenone in Chinese CKD patients without diabetes: a retrospective, real-world study [J].
Zhou, Li ;
Li, Wenge .
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2024, 56 (12) :3877-3885
[22]   Real-world evidence on siponimod treatment in patients with secondary progressive multiple sclerosis [J].
Regner-Nelke, Liesa ;
Pawlitzki, Marc ;
Willison, Alice ;
Rolfes, Leoni ;
Oezalp, Sinem-Hilal ;
Nelke, Christopher ;
Koelsche, Tristan ;
Korsen, Melanie ;
Grothe, Matthias ;
Groppa, Sergiu ;
Luessi, Felix ;
Engel, Sinah ;
Nelles, Gereon ;
Bonmann, Eckhard ;
Roick, Holger ;
Friedrich, Anke ;
Knorn, Philipp ;
Landefeld, Harald ;
Biro, Zoltan ;
Ernst, Michael ;
Bayas, Antonios ;
Menacher, Martina ;
Akgun, Katja ;
Kleinschnitz, Christoph ;
Ruck, Tobias ;
Ziemssen, Tjalf ;
Pul, Refik ;
Meuth, Sven G. .
NEUROLOGICAL RESEARCH AND PRACTICE, 2022, 4 (01)
[23]   Real-World Effectiveness and Safety of Fingolimod in Patients With Relapsing Remitting Multiple Sclerosis: A Prospective Analysis in Buenos Aires, Argentina [J].
Patrucco, Liliana ;
Cristiano, Edgardo ;
Sanchez, Francisco ;
Miguez, Jimena ;
Rojas, Juan Ignacio .
CLINICAL NEUROPHARMACOLOGY, 2019, 42 (05) :163-166
[24]   Real-World Use of Fingolimod in Patients with Relapsing Remitting Multiple Sclerosis: A Retrospective Study Using the National Multiple Sclerosis Registry in Kuwait [J].
Jasem AL-Hashel ;
Samar F. Ahmed ;
Raed Behbehani ;
Raed Alroughani .
CNS Drugs, 2014, 28 :817-824
[25]   Real-World Use of Fingolimod in Patients with Relapsing Remitting Multiple Sclerosis: A Retrospective Study Using the National Multiple Sclerosis Registry in Kuwait [J].
AL-Hashel, Jasem ;
Ahmed, Samar F. ;
Behbehani, Raed ;
Alroughani, Raed .
CNS DRUGS, 2014, 28 (09) :817-824
[26]   Safety and effectiveness of ocrelizumab in multiple sclerosis: a real-world study from spain [J].
Sempere, A. ;
Berenguer-Ruiz, L. ;
Burgos-San Jose, A. ;
Aragones, M. ;
Navarro-Lopez, M. D. .
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) :553-553
[27]   Real-World Effectiveness of Disease-Modifying Therapies in Korean Patients with Relapsing Multiple Sclerosis [J].
Kim, Su-Hyun ;
Park, Min Su ;
Kim, Woojun ;
Huh, So-Young ;
Shin, Hyun-June ;
Hyun, Jae-Won ;
Kim, Ho Jin .
JOURNAL OF CLINICAL NEUROLOGY, 2019, 15 (01) :20-26
[28]   Real-world effectiveness of fingolimod in Polish group of patients with relapsing-remitting multiple sclerosis [J].
Walczak, Agata ;
Kurkowska-Jastrzebska, Iwona ;
Zakrzewska-Pniewska, Beata ;
Dorobek, Malgorzata ;
Brola, Waldemar ;
Zajdel, Radoslaw ;
Bartosik-Psujek, Halina ;
Stasiolek, Mariusz ;
Kulakowska, Alma ;
Rusek, Stanislaw ;
Tutaj, Andrzej ;
Glabinski, Andrzej ;
Wlodek, Agata ;
Kochanowski, Jan ;
Ciach, Agnieszka ;
Siger, Malgorzata ;
Kurowska, Katarzyna ;
Wicha, Wojciech ;
Nojszewska, Monika ;
Podlecka-Pietowska, Aleksandra ;
Czajka, Anna ;
Kapica-Topczewska, Katarzyna ;
Bielecki, Bartosz ;
Maciagowska-Terela, Marzena ;
Stepien, Adam .
CLINICAL NEUROLOGY AND NEUROSURGERY, 2019, 184
[29]   Real-world effectiveness of fingolimod in Polish group of patients with relapsing-remitting multiple sclerosis [J].
Walczak, A. ;
Kurkowska-Jastrzebska, I. ;
Zakrzewska-Pniewska, B. ;
Dorobek, M. ;
Brola, W. ;
Zajdel, R. ;
Bartosik-Psujek, H. ;
Kulakowska, A. ;
Rusek, S. ;
Tutaj, A. ;
Glabinski, A. ;
Wlodek, A. ;
Kochanowski, J. ;
Stepien, A. .
MULTIPLE SCLEROSIS JOURNAL, 2019, 25 :328-328
[30]   Efficacy and safety of ocrelizumab in patients with relapsing multiple sclerosis: Real-world experience of two Swiss multiple sclerosis centers [J].
Diem, L. ;
Ovchinnikov, A. ;
Friedli, C. ;
Hammer, H. ;
Kamber, N. ;
Chan, A. ;
Salmen, A. ;
Findling, O. ;
Hoepner, R. .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 86